- Home
- NNOX vs GEVO Comparison
NNOX vs GEVO Comparison
Compare NNOX & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- GEVO
- Stock Information
- Founded
- NNOX 2011
- GEVO 2005
- Country
- NNOX Israel
- GEVO United States
- Employees
- NNOX N/A
- GEVO N/A
- Industry
- NNOX Medical Electronics
- GEVO Major Chemicals
- Sector
- NNOX Health Care
- GEVO Industrials
- Exchange
- NNOX Nasdaq
- GEVO Nasdaq
- Market Cap
- NNOX 248.7M
- GEVO 418.4M
- IPO Year
- NNOX 2020
- GEVO 2011
- Fundamental
- Price
- NNOX $3.85
- GEVO $1.73
- Analyst Decision
- NNOX Strong Buy
- GEVO Buy
- Analyst Count
- NNOX 2
- GEVO 2
- Target Price
- NNOX $8.50
- GEVO $7.58
- AVG Volume (30 Days)
- NNOX 1.3M
- GEVO 9.4M
- Earning Date
- NNOX 08-12-2025
- GEVO 08-11-2025
- Dividend Yield
- NNOX N/A
- GEVO N/A
- EPS Growth
- NNOX N/A
- GEVO N/A
- EPS
- NNOX N/A
- GEVO N/A
- Revenue
- NNOX $11,886,000.00
- GEVO $80,187,000.00
- Revenue This Year
- NNOX $24.12
- GEVO $909.99
- Revenue Next Year
- NNOX $160.56
- GEVO $22.37
- P/E Ratio
- NNOX N/A
- GEVO N/A
- Revenue Growth
- NNOX 17.36
- GEVO 341.75
- 52 Week Low
- NNOX $3.75
- GEVO $0.67
- 52 Week High
- NNOX $11.00
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- NNOX 32.78
- GEVO 57.77
- Support Level
- NNOX $3.88
- GEVO $1.54
- Resistance Level
- NNOX $4.16
- GEVO $1.86
- Average True Range (ATR)
- NNOX 0.19
- GEVO 0.14
- MACD
- NNOX -0.02
- GEVO 0.01
- Stochastic Oscillator
- NNOX 8.44
- GEVO 31.15
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.